Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 11 Similar Profiles
Graft vs Host Disease Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Mortality Medicine & Life Sciences
Recurrence Medicine & Life Sciences
Acute Myeloid Leukemia Medicine & Life Sciences
Incidence Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2036

Research Output 2008 2017

  • 332 Citations
  • 8 Scopus h-Index
  • 18 Article
  • 4 Review article
  • 2 Comment/debate
1 Citations

A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation

Magenau, J. , Westervelt, P. , Khaled, S. , McGuirk, J. , Hari, P. , Eapen, M. , Becker, P. S. , Parkin, B. , Braun, T. , Logan, B. , Wang, H. , Jagasia, M. , Rowley, S. D. , Kim, D. D. H. , Schechter, T. , Frey, N. , Scott, B. , Churay, T. , Lieland, S. , Forman, S. & 1 others Mineishi, S. Jan 1 2017 In : Bone Marrow Transplantation. 52, 1, p. 59-65 7 p.

Research output: Research - peer-reviewArticle

Busulfan
Hematopoietic Stem Cell Transplantation
Cell Transplantation
Multicenter Studies
clofarabine

B-cell activating factor (BAFF) plasma level at the time of chronic GvHD diagnosis is a potential predictor of non-relapse mortality

Saliba, R. M., Sarantopoulos, S., Kitko, C. L., Pawarode, A., Goldstein, S. C., Magenau, J., Alousi, A. M., Churay, T., Justman, H., Paczesny, S., Reddy, P. & Couriel, D. R. Jul 1 2017 In : Bone Marrow Transplantation. 52, 7, p. 1010-1015 6 p.

Research output: Research - peer-reviewArticle

B-Cell Activating Factor
Mortality
Elafin
Ligands
CXC Chemokines
3 Citations

Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease

Miller, H. K., Braun, T. M., Stillwell, T., Harris, A. C., Choi, S., Connelly, J., Couriel, D., Goldstein, S., Kitko, C. L., Magenau, J., Pawarode, A., Reddy, P., Riwes, M., Yanik, G. A. & Levine, J. E. Mar 1 2017 In : Biology of Blood and Marrow Transplantation. 23, 3, p. 522-528 7 p.

Research output: Research - peer-reviewArticle

Hematopoietic Stem Cell Transplantation
Cell Transplantation
Graft vs Host Disease
Infection
Bacterial Infections
1 Citations

Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT

Choi, S. W., Braun, T., Henig, I., Gatza, E., Magenau, J., Parkin, B., Pawarode, A., Riwes, M., Yanik, G., Dinarello, C. A. & Reddy, P. Oct 12 2017 In : Blood. 130, 15, p. 1760-1767 8 p.

Research output: Research - peer-reviewArticle

Unrelated Donors
Cell Transplantation
Tacrolimus
Graft vs Host Disease
Methotrexate
9 Citations

Advances in understanding the pathogenesis of graft-versus-host disease

Magenau, J., Runaas, L. & Reddy, P. Apr 1 2016 In : British Journal of Haematology. 173, 2, p. 190-205 16 p.

Research output: Research - peer-reviewReview article

Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Inflammation Mediators
Epigenomics
Immunotherapy